HPLC-MS/MS for NDMA impurity determination in sartans
EPR summarises the development of a HPLC method for the detection, separation and quantification of N-nitrosodimethylamine (NDMA) in both olmesartan API and finished formulations.
Drug Administration International Conference On Harmonization Microchemical Journal Agilent Eclipse International Conference
Source: europeanpharmaceuticalreview.com